Literature DB >> 9602426

Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency.

M Kuwajima1, K Lu, M Sei, A Ono, M Hayashi, K Ishiguro, K Ozaki, K Hotta, K Okita, T Murakami, J Miyagawa, I Narama, H Nikaido, J Hayakawa, H Nakajima, M Namba, T Hanafusa, Y Matsuzawa, K Shima.   

Abstract

The juvenile visceral steatosis (JVS) mouse exhibits hereditary systemic carnitine deficiency and develops cardiac hypertrophy. The aim of this study was to clarify the characteristics of cardiac hypertrophy in the JVS mouse. Total carnitine content in IVS mouse heart was about 10% of that of control mouse heart at 4 and 8 weeks of age. The heart weight/body weight ratio was bigger in JVS mice than that in control mice at 2 weeks of age, and this difference in ratio increased with age. The wall areas of both ventricles and septum in JVS mice were larger than those of the control mice at 2 and 8 weeks. The myocyte diameter in both ventricular walls and septum in JVS mice was longer than that of the control mice. On electron microscopy, the percent of mitochondria in the myocyte was 66% in JVS mice, and 37% in control mice. The percent of lipid fraction in JVS mice was six-fold higher than that in control mice. Total content of adenine nucleotides in JVS mouse heart was about 60% of that in control mouse heart. Adenylate energy charge in JVS mouse heart was 63 and 45% of that in the control mouse heart at 4 and 8 weeks, respectively. Overall, the cardiac enlargement observed in this animal model could be accounted for by a proportional increase in the myocyte diameter in the ventricles and septum, accompanied by an increase in mitochondria. Furthermore, this cellular growth is associated with decreases in the levels of ATP and ADP, and adenylate energy charge.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602426     DOI: 10.1006/jmcc.1998.0641

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  3 in total

1.  Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats.

Authors:  Salim S Al-Rejaie; Abdulaziz M Aleisa; Abdulaziz A Al-Yahya; Saleh A Bakheet; Abdulmalik Alsheikh; Amal G Fatani; Othman A Al-Shabanah; Mohamed M Sayed-Ahmed
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

2.  Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).

Authors:  Harunobu Tahara; Sook Wah Yee; Thomas J Urban; Stephanie Hesselson; Richard A Castro; Michiko Kawamoto; Doug Stryke; Susan J Johns; Thomas E Ferrin; Pui-Yan Kwok; Kathleen M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

3.  Primary carnitine deficiency - diagnosis after heart transplantation: better late than never!

Authors:  Sarah C Grünert; Sara Tucci; Anke Schumann; Meike Schwendt; Gwendolyn Gramer; Georg F Hoffmann; Michelle Erbel; Brigitte Stiller; Ute Spiekerkoetter
Journal:  Orphanet J Rare Dis       Date:  2020-04-10       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.